Dr Sameer Mistry is a member of the Audit and Risk Management Committee. Sameer is a senior industry physician leader with more than 18 years’ experience in pharmaceuticals, medical devices and consumer healthcare across multiple disease areas. He is currently Global Medical Lead, Early Drug Development at GSK, prior to which he held other senior roles at GSK and at Johnson & Johnson. Before joining the industry, Sameer was a doctor in the UK NHS and a qualified member of the Royal College of Surgeons of Edinburgh.
Dr Sameer Mistry
Latest news
-
Introducing Raremap: a new way to navigate the rare disease landscape
-
LifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
-
New boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc